As multinational stent makers ponder their prospects in India after price controls introduced this year, their local rivals have popped up ...

Through this move, NPPA has plugged the gap for ‘manipulating’ trade margins in coronary stents, the regulator’s chairman stated on Twitter.

Now, patients purchasing stents at their maximum price won’t pay hospitals margins of more than Rs 2,400 on DES and BVS and about Rs 581 on...

Following the NPPA decision, some companies have reportedly withdrawn high-priced stents, leading to an artificial shortage of the product.

A cardiologist who spoke to ET on condition of anonymity said some companies, especially importers, have asked hospitals not to use stents ...

There are reports of shortages of stents in hospitals after the government reduced their prices by up to 85 per cent by capping rates of ba...

The move, which has upset domestic and multinational stent makers alike, would encourage companies to make in India to cut costs, the minis...

In a notification, the drug regulator has capped the ceiling prices of stentsat Rs 29,600, which currently costs between Rs 40,000 to Rs 1....

While the biggest jump in price seems to happen at the level of hospitals, not all hospitals might be charging that high a margin as it ran...

The drug-pricing regulator's proposals have added fuel to an ongoing debate about which formula for capping these devices would improve pat...

Indian stents are not drastically cheaper to imported stents, says the Medical Technology Association of India

Bioresorbable scaffolds showed that the device might perform as well as a metallic stent clinically , but it also meant an “increased risk“...

Since hospitals implant the stent, they also become de facto retailers as the devices cannot be bought in the open market.

The drug pricing watchdog stated that few companies still have not submitted the information and that some of them have not submitted the d...

The report, coming in the backdrop of the government's moves to control prices of stents and other such medical devices.

Most patients are forced to pay anything between Rs 60,000 and Rs 1 lakh or more for cardiac drug eluting stents (DES).

Following Johnson & Johnson’s (J&J) announcement that it will withdraw Conor Medsystem’s heart stent from the Indian market after the produ...